Drug sector warns patients will be denied new therapies
Representatives of the pharmaceutical industry have appealed to the Health Ministry not to proceed with legislation that they say will limit access to new therapies.
According to the Hellenic Association of Pharmaceutical Companies (SFEE), the new legislation, to be submitted to Parliament in the coming days, will stipulate that a new drug can only be distributed on the Greek market if it receives a positive Health Technology Assessment (HTA) in six European Union countries – namely the UK, France, Italy, Portugal, Sweden and Spain. HTA is the systematic evaluation of the properties and effects of a health technology.
SFEE president Akis Apostolides said the proposed measures will hinder the access of patients to “innovative therapies” as their introduction to Greece will be delayed by two to four years or even more.
On average, it takes roughly 21 months before a new drug is approved and allowed on the Greek market, while in the EU the average time is 3.9 months.
You may be interested
Poll: New Democracy leads with a 14.8% difference to SYRIZAmakis - Jun 24, 2021
The governing party of New Democracy is clearly leading the polls with 37%, a difference of 14.8% from SYRIZA which…
Greece and Italy top European picks for American touristsPanos - Jun 24, 2021
Italy and Greece are the top two choices in Europe for American travellers this season, according to a report by…
Turkish coastguard harassed Cypriot fishing boat (photos)Panos - Jun 24, 2021
New provocation from Turkey. Turkish coastguards harassed the fishing boat “Maria – Bouboulina”, while sailing in international territorial waters. The…